A specialist post-harvest facility transforming GACP-compliant cannabis flower into EU-GMP certified medical products — from cultivation partner to international market.
Delta-Nine Pharmaceuticals is a specialist post-harvest cannabis processing company based in South Africa's Cape Winelands. We partner with SAHPRA-licensed cultivators, purchasing GACP-compliant cannabis flower and adding pharmaceutical value through our fully compliant facility.
Our mission is to ensure every processed batch meets the highest global standards for quality, safety, and consistency — enabling South African cultivators to access premium international markets with confidence.
Precision trimming and grading of cannabis flower to pharmaceutical specifications, ensuring uniformity and quality for every batch destined for global markets.
Controlled environment drying and curing processes designed to preserve terpene profiles and cannabinoid integrity while meeting strict moisture and microbiological standards.
EU-GMP compliant packaging in tamper-evident, pharmaceutical-grade containers with full regulatory labelling for international distribution and export compliance.
Climate-controlled, secure vaulted storage with real-time monitoring and full chain-of-custody documentation from intake through to dispatch.
Comprehensive in-process testing and batch release protocols aligned with EU-GMP Annex 1 standards, with full documentation packages for regulatory submissions.
End-to-end export coordination including temperature-controlled transport, permits, and regulatory documentation for international pharmaceutical markets.
We source directly from SAHPRA-licensed cultivators in South Africa's Cape Winelands, verifying GACP compliance and documentation before intake begins.
Every incoming batch is weighed, documented, and tested before entering our controlled processing environment. Batch records are opened and chain of custody begins.
Drying, curing, trimming, sorting, and grading are performed in our pharmaceutical-grade facility under strict environmental controls and continuous monitoring.
Finished product is packaged to EU-GMP specifications, labelled for target markets, and batch-released by a Qualified Person with full documentation.
Temperature-controlled logistics, import permits, and regulatory documentation coordinated for delivery to international pharmaceutical markets worldwide.
Delta-Nine Pharmaceuticals incorporated in South Africa. Facility site selection and initial planning commenced in the Cape Winelands.
CompletedProcessing facility constructed to pharmaceutical-grade specifications. Quality Management System development and SOP drafting initiated.
CompletedFull application package being prepared for submission to SAHPRA for a cannabis-related licence. Documentation, facility inspection readiness and compliance review underway.
In ProgressAnticipated award of SAHPRA cannabis-related licence, enabling legal post-harvest processing and commercial operations at our Western Cape facility.
UpcomingCommencement of commercial post-harvest processing for SAHPRA-licensed cultivator partners. Initial batch records, QA protocols and supply agreements activated.
UpcomingConfirmed EU-GMP inspection by a European Medicines Agency recognised auditing body. Successful certification will unlock direct supply to EU pharmaceutical markets.
Key MilestoneFull EU-GMP certification received. Commencement of exports to European and international pharmaceutical markets. Qualified Person batch release operations go live.
UpcomingOur facility and processes are designed from the ground up to meet the rigorous requirements of both South African and international pharmaceutical regulators — ensuring every product leaving our facility is export-ready.
We operate in full alignment with SAHPRA licensing requirements and EU-GMP guidelines, with robust quality management systems, batch traceability, and environmental monitoring at every stage.
All incoming flower is verified against GACP documentation from licensed cultivators before acceptance into our facility.
Classified cleanrooms and controlled zones maintain pharmaceutical-grade environmental conditions throughout processing.
Full electronic batch records from intake to release, providing complete traceability for every unit produced.
Qualified Person (QP) batch release and full documentation packages prepared for target market submissions.
Whether you're a SAHPRA-licensed cultivator looking for a compliant processing partner, or an international buyer seeking reliable EU-GMP certified supply, we'd like to hear from you.